FI113475B - Gene Expression Unit of HIV Proteins and Production of HIV Proteins in Drosophila Cells - Google Patents

Gene Expression Unit of HIV Proteins and Production of HIV Proteins in Drosophila Cells

Info

Publication number
FI113475B
FI113475B FI912635A FI912635A FI113475B FI 113475 B FI113475 B FI 113475B FI 912635 A FI912635 A FI 912635A FI 912635 A FI912635 A FI 912635A FI 113475 B FI113475 B FI 113475B
Authority
FI
Finland
Prior art keywords
hiv proteins
production
gene expression
expression unit
drosophila cells
Prior art date
Application number
FI912635A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI912635A0 (en
Inventor
Hanne Ranch Johansen
Martin Rosenberg
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of FI912635A0 publication Critical patent/FI912635A0/en
Application granted granted Critical
Publication of FI113475B publication Critical patent/FI113475B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/75—Vector systems having a special element relevant for transcription from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI912635A 1988-12-01 1991-05-31 Gene Expression Unit of HIV Proteins and Production of HIV Proteins in Drosophila Cells FI113475B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27838688A 1988-12-01 1988-12-01
PCT/US1989/005155 WO1990006358A1 (en) 1988-12-01 1989-11-29 Expression of hiv proteins in drosophila cells

Publications (2)

Publication Number Publication Date
FI912635A0 FI912635A0 (en) 1991-05-31
FI113475B true FI113475B (en) 2004-04-30

Family

ID=23064787

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912635A FI113475B (en) 1988-12-01 1991-05-31 Gene Expression Unit of HIV Proteins and Production of HIV Proteins in Drosophila Cells

Country Status (12)

Country Link
EP (1) EP0446272A4 (en)
JP (1) JP3085704B2 (en)
KR (1) KR0152525B1 (en)
AU (1) AU630649B2 (en)
CA (1) CA2003794C (en)
DK (1) DK175461B1 (en)
FI (1) FI113475B (en)
IL (1) IL92470A (en)
NO (1) NO314090B1 (en)
PT (1) PT92477A (en)
WO (1) WO1990006358A1 (en)
ZA (1) ZA899150B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2739300B1 (en) * 2011-07-05 2019-06-19 Duke University N-terminal deleted gp120 immunogens
CA2850745C (en) 2011-10-03 2022-12-13 Duke University Vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272858A3 (en) * 1986-12-15 1989-07-12 Repligen Corporation Recombinant hiv envelope proteins produced in insect cells
CA1341345C (en) * 1987-05-08 2002-03-05 Hanne Ranch Johansen Expression of foreign genes in drosophila cells
AP129A (en) * 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
JPH03504082A (en) * 1988-12-21 1991-09-12 スミスクライン・バイオロジカルズ Expression of Plasmodium circumsporozoite proteins by insect cells

Also Published As

Publication number Publication date
JP3085704B2 (en) 2000-09-11
EP0446272A4 (en) 1993-01-07
IL92470A (en) 1997-01-10
EP0446272A1 (en) 1991-09-18
FI912635A0 (en) 1991-05-31
CA2003794A1 (en) 1990-06-01
KR910700344A (en) 1991-03-14
DK104991D0 (en) 1991-05-31
JPH04501954A (en) 1992-04-09
NO912099D0 (en) 1991-05-31
CA2003794C (en) 2000-02-08
IL92470A0 (en) 1990-08-31
AU630649B2 (en) 1992-11-05
KR0152525B1 (en) 1998-10-01
NO912099L (en) 1991-07-31
PT92477A (en) 1990-06-29
WO1990006358A1 (en) 1990-06-14
ZA899150B (en) 1991-04-24
NO314090B1 (en) 2003-01-27
DK104991A (en) 1991-05-31
AU4755290A (en) 1990-06-26
DK175461B1 (en) 2004-11-01

Similar Documents

Publication Publication Date Title
FI893542A (en) Enzyme electrodes and method for their manufacture
DK40591A (en) THREE-DIMENSIONAL CELL AND TISSUE CULTURE SYSTEM
DE68929304D1 (en) Oligoribonucleotide derivatives and their use as antiviral drugs
ATE207125T1 (en) ANTI-SENSE REGULATION OF GENE EXPRESSION IN PLANT CELLS
AU3725689A (en) Expression of retrovirus gag protein in eukaryotic cells
FI885589A (en) Manufacture and use of a protein product
PT89121A (en) PROCESS FOR THE PREPARATION OF INTERLEUQUIN-2 FIXED AND INTERLEUKIN-2 CONTAINING AN EXTENSION IN THE TERMINAL-CARBOXYL WITH ACTIVITY OF INTERLEUQUIN-2 NATURAL
BR8902861A (en) PROCESS OF PREPARING AMORPHAS AND TRANSPARENT COPOLIAMIDES AND THEIR APPLICATION
PT84849A (en) ENHANCED EXPRESSION OF HUMAN INTERLEUKIN-2 IN MAMMALIAN CELLS
EP0295859A3 (en) Production of proteins in active forms
FI113475B (en) Gene Expression Unit of HIV Proteins and Production of HIV Proteins in Drosophila Cells
DE69034051D1 (en) Stably transformed yeast cells and their use in the production of albumin
DK643188A (en) EXPRESSION OF HIV PROTEINS IN E.COLI AND S.CEREVISIAE
AU2810089A (en) Production of proteins in plants
PT88556A (en) STABLE GENOMIC INTEGRATION AND EXPRESSION OF A FOREIGN CODING SEQUENCE IN YEAST
IE893803L (en) Expression of hiv proteins in drosophila cells
AU1501088A (en) Production of proteins in active forms
PT86588A (en) KASSETTEN-VEKTOR-SYSTEM ZUR EXPRESSION OFFENER LESERAHMEN IN EUKARYOTICHEN ZELLEN
DE58901122D1 (en) USE OF TNF AND LT IN THE PRODUCTION OF MEDICINAL PRODUCTS.
ATE59407T1 (en) EXPRESSION OF EPA IN MAMMALIAN CELLS.
ES550064A0 (en) IMPROVEMENTS IN THE MANUFACTURE OF CARTON AND SIMILAR FLUFFED BODIES
JPS645492A (en) Production of b type hepatitis virus protein in yeast
BR8405786A (en) LEVEL OF MASON WITH MEDICATION IN DEGREES AND PERCENTAGE
PT88807A (en) PROCESS FOR AMPLIFICATION OF GENES AND FOR THE ENHANCED PREPARATION OF PROTEINS IN CULTURES OF ANIMAL CELLS
GB8606728D0 (en) Culture of plasmid-containing cells